CSF3 and metabolic syndrome: Our results go in accordance with the work of Z. Hu et al. (2013) who showed that G-CSF aggravates endothelial damage and dyslipidemia, upregulates endothelin-1 expression, and downregulates eNOS in the arterial wall [33].